Table of Contents

company-logo

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company's ophthalmic product offering and pipeline of product candidates include DiagnosTear's TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.

BioLight Life Sciences Dividend Announcement

• BioLight Life Sciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on BioLight Life Sciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

BioLight Life Sciences Dividend History

BioLight Life Sciences Dividend Yield

BioLight Life Sciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing BioLight Life Sciences stock? Use our calculator to estimate your expected dividend yield:

BioLight Life Sciences Financial Ratios

P/E ratio-3.78
PEG ratio-79.90
P/B ratio0.75
ROE-20.19%
Payout ratio0.00%
Current ratio4.39
Quick ratio4.39
Cash Ratio0.43

BioLight Life Sciences Dividend FAQ

Does BioLight Life Sciences stock pay dividends?
BioLight Life Sciences does not currently pay dividends to its shareholders.
Has BioLight Life Sciences ever paid a dividend?
No, BioLight Life Sciences has no a history of paying dividends to its shareholders. BioLight Life Sciences is not known for its dividend payments.
Why doesn't BioLight Life Sciences pay dividends?
There are several potential reasons why BioLight Life Sciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will BioLight Life Sciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While BioLight Life Sciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is BioLight Life Sciences a dividend aristocrat?
BioLight Life Sciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is BioLight Life Sciences a dividend king?
BioLight Life Sciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is BioLight Life Sciences a dividend stock?
No, BioLight Life Sciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy BioLight Life Sciences stocks?
To buy BioLight Life Sciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy BioLight Life Sciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.